1 Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180), Tübingen, Germany.
2 Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
3 Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tübingen, Tübingen, Germany.
4 Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180), Tübingen, Germany; Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
5 Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.
6 Institute of Clinical Chemistry and Pathobiochemistry, Central Institute for Translational Cancer Research (TranslaTUM), Technical University of Munich, Munich, Germany.
7 Department of Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
8 Institute for Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany.
9 Department of Dermatology and Allergology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
10 Institute of Pathology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
11 Department of Dermatology, University Hospital of Zürich, University of Zürich, Zürich, Switzerland.
12 Institute of Experimental Oncology, University Hospital of Bonn, Bonn, Germany.
13 Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tübingen, Tübingen, Germany; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland; Department of Dermatology and Allergology, Kantonsspital St. Gallen, St. Gallen, Switzerland. Electronic address: lukas.flatz@med.uni-tuebingen.de.